Most startups raising a seed or Series A round don't have granted patents. Many don't even have pending applications. Patent examination takes two to three years on average, and most founders are raising capital well before that timeline plays out.
Investors know this. They're not expecting a portfolio of granted patents from a company that incorporated eighteen months ago. But they are expecting to see that you've thought about IP, that you actually own what you've built, and that you have a plan for protecting it. An empty IP section can convey "we haven't thought about this," and that's a different signal entirely.
Here's what actually belongs in the IP section of your data room when you don't have patents yet, why each piece matters, and what to do if you're missing any of it.
What investors are actually looking for at seed stage
Before getting into specific documents, it helps to understand what's going through an investor's mind when they open the IP folder.
At seed stage, diligence is relatively light. Investors aren't doing the kind of deep prosecution analysis or claim scope review that comes at Series B or during an acquisition. What they're doing is checking for red flags and looking for signals that you're building a defensible business.
The red flags are straightforward. Does the company actually own its technology? Has anyone disclosed the invention publicly before filing? Are there obvious prior art issues that would make the core technology unpatentable? Has a co-founder or early contractor walked away with IP that should belong to the company?
The positive signals are equally straightforward. Has the team identified what's patentable about their technology? Have they taken the basic steps to protect it? Do they have a plan for building an IP position over time?
You don't need a portfolio of granted patents to pass this test. You need documentation that shows you're operating with intention.
The IP documents that belong in your data room
1. IP assignment agreements
This is the single most important document in your IP folder, and it's the one most commonly missing.
An IP assignment agreement is a signed contract transferring ownership of intellectual property from individuals (founders, employees, contractors) to the company. Without it, there's a legal argument that the people who built your technology own it personally, not the company that investors are putting money into.
Under U.S. law, the default rule for freelancers and contractors is that they own what they create unless there's a written agreement saying otherwise. The "work made for hire" doctrine has narrower limits than most founders assume, and it doesn't cover most software, hardware designs, or technical innovations created by contractors.
A VC partner at a well-known fund once put it bluntly: "I do not care how many patents you have filed. I care whether every person who ever wrote a line of code signed an IP assignment." That's not hyperbole. Disputed ownership is one of the most common reasons startups fail due diligence before a Series A round.
What to include:
- Signed Proprietary Information and Inventions Assignment Agreements (PIIAs) from every founder
- IP assignment clauses from employment agreements for every engineer, designer, or technical contributor
- Contractor agreements with explicit IP assignment language for anyone who contributed to the product before they were an employee
- If any IP was developed before the company was incorporated, a pre-incorporation IP assignment transferring that work to the company
If you're missing this: Fix it before you open the data room. Chase down signatures from every person who contributed to building the product. If a former contractor or co-founder is unresponsive, flag it with your attorney now rather than discovering the gap mid-diligence. This is one of the biggest filing mistakes startups make, and it's entirely avoidable.
2. Patent filings (if you have them)
You may not have granted patents, but if you've filed anything — even a provisional application — include it.
What to include:
- Filing dates and serial numbers for any provisional or pending non-provisional applications
- USPTO filing receipts confirming "patent pending" status
- A brief summary of what each application covers and how it maps to your product
Note that if the technology covered by a provisional is already in your product or has been publicly disclosed elsewhere (a demo, a conference, a published paper), sharing the full provisional with investors is fine, since the information isn't secret anymore. But if the provisional covers technology that hasn't been disclosed yet (features in development, next-generation approaches, inventions not yet reflected in the product), think carefully before including the full application. Provisionals are not publicly available through the USPTO, so sharing one is a deliberate choice to make the technology inside it known. In that case, a brief summary of what the application covers is sufficient for diligence purposes.
If you haven't filed: That's actually a fine position to be in, as long as you haven't publicly disclosed the invention in a way that triggers the one-year statutory bar. If you're raising soon and want "patent pending" status before you open the data room, a provisional application can typically be filed in days with a tool like Patentext.
3. IP strategy memo
This is the document that puts everything else in context. It answers the question: "What's your plan for building and protecting your IP position over the next 12-24 months?"
An IP strategy memo doesn't need to be long. A page or two is usually plenty. But it should demonstrate that you've thought about defensibility in a structured way, not just "we should probably file some patents."
What to include:
- Which inventions you plan to file patent applications on, and your expected timeline
- Whether you're pursuing provisional or non-provisional filings first, and why
- How your patent strategy connects to your product roadmap (i.e., are you protecting the features that matter most competitively?)
- Which aspects of your technology you're protecting as trade secrets rather than patents, and why
- Any international filing considerations, if relevant at your stage
- Your budget and resource allocation for IP over the next 12–24 months
Investors, especially those investing in deep tech, want to see that your IP strategy aligns with your business strategy. A startup building novel sensor hardware that plans to file patents on the core detection mechanism demonstrates more strategic thinking than one that has a vague intention to "get some patents at some point."
If you're not sure where to start, Patentext lets you build your patent strategy for free — mapping your inventions, evaluating prior art risk and technical maturity, and prioritizing which concepts to file on first. You can use it to generate the kind of structured IP strategy that belongs in a data room, even before you commit to filing anything.
4. Trade secret documentation
Not everything should be patented. Some competitive advantages are better protected as trade secrets, such as proprietary datasets, manufacturing processes, optimization algorithms, customer-specific configurations.
Including trade secret documentation in your data room shows investors that you understand the difference and have made deliberate choices about what to protect and how.
What to include:
- A trade secret inventory listing the company's key proprietary information (at a summary level. You absolutely should not reveal the secrets themselves in the data room)
- Evidence of reasonable protection measures: NDAs with employees and contractors, access controls on proprietary code or data, confidentiality provisions in partnership agreements
- Documentation of your confidentiality policies and procedures
An important note on what not to share here: don't disclose the actual trade secrets themselves. Most investors won't sign an NDA, since it's impractical for firms that see hundreds of deals across overlapping technology areas. However, this means anything you share in the data room should be treated as unprotected. A high-level inventory of what you consider proprietary, evidence that you have protection measures in place, and documentation of your confidentiality policies are what investors need to see. They don't need (and you shouldn't provide) the actual technical details of your trade secrets.
5. Open source and third-party IP audit
If your product uses open source software (and it almost certainly does), investors will want to know what licenses you're operating under and whether any of them create obligations that could affect the company's IP position.
What to include:
- A list of all open source components used in the product, with their licenses (MIT, Apache, GPL, etc.)
- A note on any copyleft licenses (GPL, AGPL) that could require you to open-source your own code
- A summary of any third-party IP you've licensed (APIs, SDKs, datasets, patents) and the terms of those licenses
- Confirmation that you're not using any third-party IP without authorization
This is especially important for AI/ML startups using training data, pre-trained models, or third-party APIs that may have restrictions on commercial use or derivative works.
6. Trademark filings
Trademarks are a different form of IP, but they belong in the same section of your data room. If you've registered (or applied for) trademarks on your company name, product name, or logo, include the documentation. Even if you haven't formally registered, a brief note on your common law trademark rights (established through use in commerce) shows awareness.
What NOT to put in your data room
Don't include confidential technologies
This is the most important rule, and it applies across the board. Trade secrets, unfiled patent disclosures, and invention details that haven't been made public should not belong in a data room that investors will access without signing a confidentiality agreement.
Once confidential information is shared without protection, you risk destroying the very IP rights you're trying to showcase. Include summaries, filing receipts, and strategy documents. Keep the actual technical details under wraps until the appropriate stage of the relationship.
Don't include a "patent landscape" report you didn't commission
Some founders run a quick Google Patents search, paste the results into a document, and call it a prior art analysis. If it's not thorough enough to inform your own filing strategy, it won't impress an investor and might actually hurt if it surfaces problematic prior art that you haven't addressed.
Don't include applications you haven't actually filed
Draft applications sitting on your hard drive are not "patent pending" and shouldn't be described that way. If you're planning to file, say so in your IP strategy memo. Don't put unsubmitted drafts in the data room as if they're filed applications.
Don't overstate the strength of provisional applications
A provisional establishes a priority date and gives you patent pending status, but it doesn't get examined, doesn't have formal claims (in most cases), and can be rendered worthless by a weak specification. Be straightforward about what your provisionals cover and what your plan is for converting them to non-provisionals.
Don't leave the IP section empty
An empty folder is the worst possible signal. Even if you have nothing filed, you should have IP assignments, invention disclosures, and a strategy memo. Those three documents together take less time to prepare than a pitch deck.
The priority order if you're starting from scratch
If your raise is coming up and your IP section is currently empty, here's the order to tackle things:
- This week: Get IP assignment agreements signed by every founder, employee, and contractor who contributed to building the product. This is non-negotiable, and it costs nothing except the time to get signatures.
- Next two weeks: Write invention disclosures for your two or three most important technical innovations, and draft a one-page IP strategy memo explaining your plan for the next 12-24 months. If you'd rather not start from a blank page, Patentext's platform can generate both automatically — the strategy module maps your inventions against prior art and business relevance, and the disclosure module walks you through structured technical capture. The free tier covers up to three strategy documents; the Discovery plan at $30/month gives you unlimited strategy and disclosure generation.
- Before you open the data room: If budget allows, file at least one provisional patent application on your core technology. A well-drafted provisional costs $2,500 to $5,000 depending on the path you choose and can be done in days. "Patent pending" in your data room is a meaningfully stronger signal than "we plan to file." If you've already built your disclosures on the Patentext platform, they flow directly to our registered patent agents for drafting and filing at a $2,500 flat fee.
- Ongoing: Compile your open source audit, trade secret inventory, and any trademark documentation. These are background tasks that can happen in parallel with the above.
Disclaimer: This article is for informational purposes only and does not constitute legal advice. Patent laws are complex and vary by jurisdiction. For personalized guidance, consult a qualified patent attorney or agent.
